More recently, we further demonstrated that injection therapy of anti-IL-6R antibodies suppressed the tumor growth of SW480 xenograft and attenuated the proliferation marker Ki-67, along with down-regulating JAK/STAT3, PI3K/AKT, and MEK/ERK-1/-2 signaling pathways [16]. Here, IL6R is linked to neoplasm.